Figure 2.
Survival outcomes in the study. (a) Serum level of miR-122 was significantly lower in the HCC patients (n = 588) than in the controls (n = 588). “∗” Indicates P < 0.001. (b–e) The patients were divided into miR122_H group (n = 294) and miR122_L group (n = 294). PFS and OS in the two groups were compared at the 12th week and 24th week using Kaplan–Meier survival analysis.